Adult men and women will naturally encounter changes in hair thickness and hair density with age. This process of hair loss is known as adult alopecia and varies by individual. Researchers have definitively linked most cases of adult-onset alopecia to normal aging, genetics and overall health.

TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada to market the Venus Bliss MAX™ system in Canada. The Venus Bliss MAX was first available in the United States in early 2022 and subsequently offered in approved jurisdictions around the world. The Venus Bliss MAX™ is a 3-in-1 body shaping solution featuring three of Venus Concept’s market leading technologies in one complete platform, including diode laser for Fat Reduction treatments, our proprietary (MP)2 applicator that combines Multi-Polar Radio Frequency with Pulsed Electro Magnetic Fields and advanced VariPulse™ technology for Cellulite Reduction and Skin treatments, and the Company’s FlexMax EMS applicators for Muscle Toning and Conditioning. “Venus continues to expand the availability of our flagship body platform, the Venus Bliss MAX, with our entry into Canada, providing our customers a comprehensive solution to deliver multiple advanced non-invasive body treatments in one system,” said Dr. Hemanth Varghese, President and Chief Operating Officer of Venus Concept. “Clinicians and aesthetic practices of all experiences and size in the Canadian market will benefit from this unique combination of proprietary technologies, further elevating the results they can deliver to the evolving aesthetic marketplace.”

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announces the successful completion of its NEXThetics events held across several major cities in North America. NEXThetics events bring together Venus Concept’s network of aesthetic leaders and practitioners and have seen a significant increase in popularity and attendance. Since our pilot events, the Company has hosted thousands of registrants, including its largest gathering to date in Houston, Texas on June 22, 2024. “NEXThetics Houston was an outstanding event, centering on the core principles of the latest technology, networking, and delivering an unparalleled experience among attendees,” says Dr. Cheryl Haseeb of Pura Medical Aesthetics in Houston, Texas. “The attendees were highly engaged and eager to learn about the science behind this cutting-edge brand. They left energized and inspired to take their practice to the next level. It's truly inspi

TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada to market the Venus Versa™ Pro system in Canada. The Venus Versa™ Pro is a comprehensive aesthetic platform which houses the latest technologies in one device to offer a total skin rejuvenation experience. The synergizing of Intense Pulsed Light (IPL) with SmartPulse™, NanoFractional Radio Frequency with SmartScan™, and Venus Concept's proprietary (MP)2 technology enable clinicians to provide a range of procedures to enhance skin tone, improve tightness and smooth texture. “We are excited to bring to the Canadian market our latest device, the Venus Versa Pro, for practitioners to offer our best in-class aesthetic technologies,” said Dr. Hemanth Varghese, President and Chief Operating Officer of Venus Concept. “Venus continues to grow our product offering globally and we look forward to customers in Canada to experience the best in-class skin treatments that the Venus Versa Pro has to offer.”

TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announces the launch of “NEXThetics”, its new series of customer education and training events. NEXThetics is the newest advancement under the Company’s recent “Venus Aesthetic Intelligence” (or “Venus AI”) rebrand. NEXThetics events also provide professionals from all sectors of the aesthetics industry a networking opportunity to come together and exchange ideas, share success stories, and forge valuable connections. “As we continue to evolve under the Venus AI banner, we are enhancing our focus on physician education and practice enhancement programs by empowering professionals in the aesthetics field with the knowledge, tools, and support they need for them to thrive. Aesthetic intelligence is not just about our emerging technologies such as robotics or artificial intelligence but about how we shift our focus from device performance to total practice performance,” said Ross Portaro, Executive Vice President, and General Manager, Global Sales and Marketing. “This transition requires focusing on how we educate and train attendees on all aspects of running a successful practice, leveraging our technologies and services to grow their businesses.” During NEXThetics events, attendees can experience live demonstrations led by top physicians, showcasing the effectiveness and versatility of Venus devices and services. Over the last four months, the Company hosted several pilot events in Dallas, Miami, Toronto, and Atlanta, which have been well received by customers and industry professionals. In these events, leading industry luminaries including Dr. Scott Gerrish, Dr. Gilly Munavalli and others shared their hands-on experience with the audience, presented success stories, and discussed other elements that are essential in building a successful practice, such as marketing programs, customer service, and post treatment care. “In 2024, we are looking to continue building on the success of our pilot NEXThetics events and drive innovation and education within aesthetics and hair restoration. Our NEXThetics program is another platform we offer to our customers that will elevate their practice and help them stay ahead of the curve,” explained Hemanth Varghese, President & Chief Operating Officer of Venus Concept. The next upcoming NEXThetic events will be held in early-June in Cleveland, Ohio and New York City, New York.

TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada to market the Venus Bliss MAX™ system in Canada. The Venus Bliss MAX was first available in the United States in early 2022 and subsequently offered in approved jurisdictions around the world. The Venus Bliss MAX™ is a 3-in-1 body shaping solution featuring three of Venus Concept’s market leading technologies in one complete platform, including diode laser for Fat Reduction treatments, our proprietary (MP)2 applicator that combines Multi-Polar Radio Frequency with Pulsed Electro Magnetic Fields and advanced VariPulse™ technology for Cellulite Reduction and Skin treatments, and the Company’s FlexMax EMS applicators for Muscle Toning and Conditioning. “Venus continues to expand the availability of our flagship body platform, the Venus Bliss MAX, with our entry into Canada, providing our customers a comprehensive solution to deliver multiple advanced non-invasive body treatments in one system,” said Dr. Hemanth Varghese, President and Chief Operating Officer of Venus Concept. “Clinicians and aesthetic practices of all experiences and size in the Canadian market will benefit from this unique combination of proprietary technologies, further elevating the results they can deliver to the evolving aesthetic marketplace.”

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has Therapeutic Goods Administration (TGA) clearance in Australia to market the Venus Versa™ Pro system. The Venus Versa Pro combines the applicator of the Venus Viva MD with the Venus Versa system which are both approved in Australia and registered in Australian Register of Therapeutic Goods (ARTG). The Venus Versa™ Pro offers a total skin rejuvenation experience by offering three powerful technologies: Intense Pulsed Light (IPL) with SmartPulse™, NanoFractional Radio Frequency with SmartScan™, and Venus' proprietary (MP)2 technology. These technologies synergize to enable customers to benefit from a wide variety of treatments to enhance skin tone, improve tightness and smooth texture. “We look forward to bringing our Venus Versa Pro system to Australia, a major market to which we continue to commit investment with a growing direct office presence,” said Dr. Hemanth Varghese, President and Chief Operating Officer of Venus Concept. “Venus Versa Pro continues to receive positive feedback from customers regarding its multi-modal system capabilities and we look to bring the device to more customers globally once approved with the relevant local authorities.”